Diversified Consumer Services
Company Overview of Yale University
Yale University is an independent research and educational institution that offers programs, departments, schools, centers, museums, and affiliated organizations. The university offers graduate and professional courses in art, architecture, divinity, drama, engineering, music, forestry and environmental studies, law, management, and medicine. Yale University was founded in 1701 and is based in New Haven, Connecticut.
206 Elm Street
New Haven, CT 06511-9992
Founded in 1701
Key Executives for Yale University
Vice President of New Haven and State Affairs
Vice President for Finance & Business Operations
Program Director of Center for Business and the Environment
Vice President for Global and Strategic Initiatives
Compensation as of Fiscal Year 2014.
Yale University Key Developments
Yale University Presents at ESG, SRI & Impact Investing Summit, Mar-30-2015 through Mar-31-2015
Mar 27 15
Yale University Presents at ESG, SRI & Impact Investing Summit, Mar-30-2015 through Mar-31-2015. Venue: The Princeton Club, New York, New York, United States. Presentation Date & Speakers: Mar-30-2015, Logan Yonavjak. Mar-31-2015, Logan Yonavjak.
Yale University Presents at Credit Suisse 18th Annual Asian Investment Conference 2015, Mar-26-2015 08:30 AM
Mar 13 15
Yale University Presents at Credit Suisse 18th Annual Asian Investment Conference 2015, Mar-26-2015 08:30 AM. Venue: Conrad Hotel, Pacific Place, 88 Queensway, Hong Kong, Hong Kong. Speakers: Robert J. Shiller, Arthur M. Okun Professor of Economics.
Boehringer Ingelheim with Yale University Collaborate to Investigate Novel Immunotherapy Targets Across Several Therapeutic Areas
Jan 13 15
Boehringer Ingelheim announced collaboration with Yale University with the goal of researching novel therapeutic targets in the field of immune-modulation. Immune-modulation refers to a range of treatments aimed at harnessing a patient’s immune system to fight disease. Under the terms of the agreement, the research capabilities of Boehringer Ingelheim and Yale University will be brought together to identify new immune-modulatory agents for oncology, autoimmune and respiratory disorders. The company will provide research funding for a select number of projects and work closely with scientists at Yale University to advance this research. The company has an option to obtain an exclusive license for all of these programs under pre-agreed terms with Yale University.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|